Effects of Glucagon‐Like Peptide‐1 Receptor Agonist on Bone Metabolism and the Expression of Insulin Receptor Substrate 1 in an Osteoporotic Rat Model
International Journal of Endocrinology · 2026-01 · 2026 (1)
DOI: 10.1155/ije/4418640 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 03.03.2026. Verfasst von Yao Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China, gxmu.edu.cn. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Study aim This study aimed to investigate the effects of the GLP‐1R agonist Exendin 4 on bone metabolism and insulin receptor Substrate 1 (IRS‐1) expression in an osteoporotic (OP) rat model.
Methods
Female SD rats were ovariectomized to establish an OP model. The rats ( n = 18) were randomized into three groups: Sham + NS, OVX + NS, and OVX + Exendin 4 groups (six rats in each group). The NS and Exendin 4 were injected via the subcutaneous route. After 12 weeks of intervention, the right femurs of the rats were removed for bone morphometric analysis by micro‐CT scanning. Furthermore, bone biomechanical tests were conducted on the left femurs in the form of three‐point bending tests. Besides, the bilateral tibias were removed for bone tissue sectioning, HE staining, and detection of IRS‐1 expression via immunohistochemical staining. Moreover, the serum calcium and phosphorus levels were determined using a fully‐automatic biochemical analyzer. The serum levels of bone metabolism‐related parameters were analyzed using ELISA kits.
Results
(1) The OVX + NS group showed a significant decrease in the number and thickness of trabeculae, fractured bone scaffold structure, and multiple adipocytes in the bone marrow cavity. Moreover, the trabeculae of the OVX + Exendin 4 group were increased in number and thickness. In addition, the bone scaffold structure was restored, and the bone marrow cavity showed fewer adipocytes than the OVX + NS group. And, the OVX + Exendin 4 group showed significantly increased BMD, BV/TV, Tb.Th, Tb.N, and bone biomechanical parameter levels ( p < 0.05) and significantly decreased SMI and serum levels of BALP, OCN, and CTX‐1 ( p < 0.05). (2) Immunohistochemical staining revealed that the OVX + Exendin 4 showed significantly increased expression of IRS‐1 compared with the OVX + NS group ( p < 0.05).
Conclusion
Exendin 4 exerts its antiosteoporotic effects in OVX rats by improving BMD, restoring bone microstructures, elevating bone biomechanical parameter levels, decreasing bone turnover rate, and increasing the expression of IRS‐1 in osteoblasts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Geriatric Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China, gxmu.edu.cn.
- Department of Geriatric Medicine, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China, gxmu.edu.cn.
ORCID-Profile: Yao Ye, Yu-Ling He
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ye, Y., He, Y. L., He, J., Yang, D. Y., & Xia, N. (2026). Effects of Glucagon‐Like Peptide‐1 Receptor Agonist on Bone Metabolism and the Expression of Insulin Receptor Substrate 1 in an Osteoporotic Rat Model. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/4418640
Vancouver
Ye Y, He YL, He J, Yang DY, Xia N. Effects of Glucagon‐Like Peptide‐1 Receptor Agonist on Bone Metabolism and the Expression of Insulin Receptor Substrate 1 in an Osteoporotic Rat Model. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/4418640
BibTeX
@article{Ye2026,
author = {Ye, Yao and He, Yu-Ling and He, Jie and Yang, Dan-Yong and Xia, Ning},
title = {Effects of Glucagon‐Like Peptide‐1 Receptor Agonist on Bone Metabolism and the Expression of Insulin Receptor Substrate 1 in an Osteoporotic Rat Model},
journal = {International Journal of Endocrinology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ije/4418640}
}
EUVIMED